Drug
Bmab1700
Bmab1700: highest development phase Phase 1, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bmab1700 NCT07476326 | Phase 1 | Melanoma |
Latest
No recent events.
Follow Bmab1700 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.